Charles Schwab Investment Management »

Inhibrx Biosciences shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Inhibrx Biosciences shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $379k 27k 14.17

More positions owned by Charles Schwab Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Fundamental Us S (FNDA)
Schwab Strategic Tr 5 10yr Corp Bd (SCHI)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Home Depot (HD)

View all positions for Charles Schwab Investment Management

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
Vanguard Group
Sofinnova Ventures
Slotnik Capital
Alpine Associates Management
Millennium Management
TIG Advisors
Morgan Stanley
Ikarian Capital
Geode Capital Management
Caption Management
Marshall Wace
CSS

View all funds holding Inhibrx Biosciences